Regulatory Alert: The Legal Status of BPC 157 in Compounding and Clinical Practice Holt Law Understanding the Legal Risks of BPC 157 and Other Unapproved Peptides Holt Law FDA takes first step in possible reversal of ban on some peptides The Washington Post People are turning themselves into lab rats': the injectable peptides craze sweeping the US Well actually The Guardian The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York